Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joshua H. Lambert"'
Autor:
Rashid K. Sayyid, Anthony Hiffa, Phillip Woodruff, Michael D. Oberle, Joshua H. Lambert, Martha K. Terris, Christopher J.D. Wallis, Zachary Klaassen
Publikováno v:
Cancer Investigation. 40:743-749
We conducted a cross-sectional analysis of ClinicalTrials.gov-registered oncology randomized controlled trials between September 2019 and December 2021 to identify predictors of trial suspensions. The dataset included 1,183 oncology trials, of which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf916a3566bf8ac354407e99ac566666
https://doi.org/10.1080/07357907.2022.2104305
https://doi.org/10.1080/07357907.2022.2104305
Autor:
Hanan Goldberg, Zachary Klaassen, Rashid K. Sayyid, Atul Lodh, John Z. Benton, Christopher J.D. Wallis, Martha K. Terris, Laurence Klotz, Soum D. Lokeshwar, Phillip Woodruff, Rabii Madi, Joshua H. Lambert
Publikováno v:
Urology. 155:117-123
To investigate sociodemographic factors influencing decision of initially active surveillance (AS) prostate cancer (CaP) patients to opt for definitive therapy, and, specifically, choice of radical prostatectomy (RP) versus radiation therapy (XRT).Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70629868707f1e149b736cd2c8adff98
https://doi.org/10.1016/j.urology.2021.01.053
https://doi.org/10.1016/j.urology.2021.01.053
Publikováno v:
Urology. 168:108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b531c4ef3847b231b3e94141407988b3
https://doi.org/10.1016/j.urology.2022.06.039
https://doi.org/10.1016/j.urology.2022.06.039
Autor:
William Reed, Joshua H. Lambert, Zachary Klaassen, Christopher J.D. Wallis, Rashid K. Sayyid, Martha K. Terris, Phillip Woodruff, John Z. Benton
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Current guidelines support active surveillance (AS) for select patients with favorable intermediate risk (FIR) prostate cancer (PCa). A significant proportion of FIR PCa ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::859caa2966b49311481538f8254f0fd5
https://doi.org/10.1097/ju.0000000000002008.09
https://doi.org/10.1097/ju.0000000000002008.09
Autor:
Rashid K. Sayyid, Zachary Klaassen, Phillip Woodruff, Martha K. Terris, Laurence Klotz, Christopher J.D. Wallis, John Z. Benton, Joshua H. Lambert
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:A substantial proportion of prostate cancer (PCa) patients on active surveillance (AS) undergo definitive treatment within ten years of diagnosis. Patient sociodemographi...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd071ac2ed7a0c60d6705971f5172755
https://doi.org/10.1097/ju.0000000000002102.11
https://doi.org/10.1097/ju.0000000000002102.11
Autor:
Phillip Woodruff, Atul Lodh, John Z. Benton, Rashid K. Sayyid, Christopher J.D. Wallis, Joshua H. Lambert, William C. Reed, Martha K. Terris, Zachary Klaassen
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:782.e7-782.e14
Current guidelines support active surveillance (AS) for select patients with favorable intermediate risk (FIR) prostate cancer (CaP). A significant proportion of FIR CaP patients undergoing surgical treatment are found to have evidence of adverse pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13237682aff13b9aa01f38d8566fe54
https://doi.org/10.1016/j.urolonc.2021.02.017
https://doi.org/10.1016/j.urolonc.2021.02.017